HSR-903

Known as: HSR 903 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2017
024619972017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND Hemorrhagic shock and reperfusion (HSR) injury leads to a cascade of reactive oxygen species (ROS) production and… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2003
2003
The activity of the fluoroquinolone olamufloxacin (HSR-903) against Legionella spp. was studied in vitro and in vivo. The… (More)
Is this relevant?
2003
2003
This study was performed to characterize the protonation equilibrium at the molecular level and pH-dependent lipophilicity of… (More)
Is this relevant?
2001
2001
The in vivo activity of olamufloxacin (HSR-903), a new fluoroquinolone, was evaluated and compared with ciprofloxacin… (More)
Is this relevant?
1999
1999
The distribution of HSR-903, a new quinolone antibacterial agent, to the brain after i.v. administration to rats was low compared… (More)
  • figure 1
  • table 2
  • figure 2
  • table 1
  • table 4
Is this relevant?
1999
1999
HSR-903 [(S)-(-)-5-amino-7-(7-amino-5-azaspiro[2. 4]hept-5-yl)-1-cyclopropyl-6-fluoro-1, 4-dihydro-8-methyl-4-oxoquinoline-3… (More)
  • figure 1
  • figure 3
  • figure 2
  • table 1
  • table 2
Is this relevant?
1999
1999
We compared the in vitro antimycobacterial activity of a new fluoroquinolone, HSR-903, with strong activity against gram-positive… (More)
  • table 1
  • figure 1
Is this relevant?
1998
1998
HSR-903 is a newly synthesized quinolone antibacterial agent with low toxicity. The biliary and urinary excretion of unchanged… (More)
  • figure 1
  • table 1
  • figure 3
  • figure 2
  • table 2
Is this relevant?
1998
1998
The in vivo activity of HSR-903, a new fluoroquinolone, against major bacteria which cause respiratory tract infections was… (More)
Is this relevant?
1997
1997
The in vitro activity of the new fluoroquinolone HSR-903 was compared with those of ciprofloxacin, lomefloxacin, sparfloxacin… (More)
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?